F D Roosevelt University General Hospital Of Banska Bystrica

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for inflammatory bowel diseases such as Crohn's Disease and Ulcerative Colitis. The center's studies aim to evaluate the efficacy and safety of various targeted therapies, including biologics and small molecules, to achieve clinical remission and improve patient outcomes.

• Targeted therapies for Crohn's Disease
• Transmural healing in Crohn's Disease
• Induction and maintenance therapy for Ulcerative Colitis

Through these studies, the center contributes significantly to understanding the mechanistic profiles of new treatments, offering hope for improved management of these chronic conditions.

Specializing in neurology, the center conducts cutting-edge research on conditions such as Refractory Status Epilepticus and Multiple Sclerosis. The focus is on evaluating the efficacy, safety, and tolerability of novel therapeutic agents, including adjunctive treatments and disease-modifying therapies.

• Adjunctive treatments for Refractory Status Epilepticus
• Effectiveness of ofatumumab in Multiple Sclerosis
• Comparative studies of remibrutinib and teriflunomide

These efforts aim to enhance therapeutic strategies and improve the quality of life for patients with complex neurological disorders.

The center is a leader in nephrology research, particularly in the treatment of Immunoglobulin A Nephropathy (IgAN) and other kidney-related immune disorders. The research focuses on evaluating the efficacy of novel agents in reducing proteinuria and preserving kidney function.

• Preservation of kidney function in IgAN
• Reduction of proteinuria in immune system diseases

By advancing these studies, the center plays a crucial role in developing new therapeutic options for patients with chronic kidney diseases.

In the field of oncology, the center is dedicated to exploring innovative treatments for various cancers, including Metastatic Melanoma and Prostate Cancer. The research includes evaluating combination therapies and novel agents to improve response rates and prolong progression-free survival.

• Combination therapies for Metastatic Melanoma
• Advanced treatments for Prostate Cancer

These studies aim to provide new insights into cancer treatment, offering hope for better patient outcomes and survival rates.

The center's dermatology research focuses on conditions such as Vitiligo and Neuroblastoma, investigating the efficacy and safety of novel treatments to improve skin health and manage pigmentation disorders.

• Innovative treatments for Vitiligo
• Therapeutic strategies for Neuroblastoma

Through these efforts, the center aims to advance the understanding and treatment of complex dermatological conditions.